查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2009312

宠物保健产品市场规模、份额、趋势和预测：按动物种类、产品类型、最终用户和地区划分，2026-2034 年。

Companion Animal Health Market Size, Share, Trends and Forecast by Animal Type, Product, End User, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 136 Pages | 商品交期: 2-3个工作天内

价格

2025年全球伴侣动物医疗保健市场规模为293.7亿美元。展望未来，IMARC集团预测，该市场将以7.03%的复合年增长率从2026年增长至2034年，到2034年达到593.7亿美元。目前，北美市场处于领先地位，预计2025年将占据40.5%的市场。该地区受益于许多因素，例如宠物拥有率高、兽医医疗保健基础设施完善、宠物保险普及以及政府对动物医疗保健标准的大力支持，这些因素共同维持了强劲的需求，并支撑了伴侣动物医疗保健行业的市场份额。

受人口、经济和科技等多面向因素的共同推动，全球伴侣动物医疗保健市场正经历强劲成长。宠物日益“拟人化”，从根本上改变了宠物饲主对待动物医疗保健的方式，越来越多的人将伴侣动物视为家庭成员，并寻求高品质的医疗服务。已开发经济体和新兴经济体可支配收入的成长，提高了人们在预防保健、诊断和专科治疗方面的投资意愿。人们对通用感染疾病的认识不断提高，进一步凸显了定期兽医护理和疫苗接种计划的重要性。兽医诊断技术的进步，包括就地检验设备和先进影像系统，使得疾病的早期发现和更准确成为可能。兽医远端医疗服务的扩展，改善了服务不足地区获得医疗保健咨询的机会。此外，宠物饲养量的激增，尤其是在全球疫情期间和之后，从根本上增加了伴侣动物的总数，从而为健康相关产品和服务创造了持续增长的需求基础，这预示着全球伴侣动物医疗保健市场将呈现积极的增长前景。

由于多种因素，美国正崛起为伴侣动物健康市场的重要区域。美国拥有全球规模最大的伴侣动物群之一，从都市区到乡村，数百万家庭都饲养宠物。遍布全国的执照兽医医院、诊所和专科医疗中心网路为服务提供奠定了坚实的基础。美国农业部和食品药物管理局（FDA）等联邦机构的监管体系确保了药品核准和兽药产品安全性的严格标准。宠物保险的普及使更多饲主能够负担得起先进的治疗方案，从而鼓励他们更频繁地带宠物就诊并采用专科治疗方法。尤其值得一提的是，美国在新型生技药品和标靶治疗的研发投入尤为活跃。

伴侣动物健康市场趋势：

宠物保险的投保人数正在迅速增加。

在主要市场，宠物保险参保率的不断攀升正在显着改变伴侣动物获得医疗保健的方式。随着复杂手术和慢性病管理的兽医费用持续上涨，越来越多的饲主开始利用保险计画来应对意外的医疗支出。这种转变促使人们更多地使用先进的诊断、外科手术和专家会诊，而这些服务原本可能因为费用限製而被忽略。保险公司正日益专注于拓展产品范围，涵盖从遗传疾病到牙科护理和行为疗法等各种疾病。在北美和欧洲部分地区，雇主提供的宠物保险福利不断扩大，进一步推动了工作年龄层宠物的投保。能够实现无缝理赔管理和保险计划比较的技术平台正在降低宠物参保的门槛。

兽用生物製剂的进展

兽用生物製剂领域正经历快速的科学发展时期，这主要得益于研发投入的增加以及生物技术平台在动物医学领域的应用。基于已在人类医疗保健领域得到验证的调查方法，利用传讯RNA技术的新型疫苗製剂正被研发用于伴侣动物。单株抗体疗法正逐步进入兽医领域，为犬猫的过敏性皮肤炎和骨关节炎等疾病提供标靶治疗方案。与传统药物相比，这些疗法具有显着优势，包括高特异性、良好的安全性以及持久的疗效。北美和欧洲的监管机构正在简化高优先级兽用生物製药的核准流程，从而缩短创新产品的上市时间。产学合作正在加速从研究成果到商业性化解决方案的转化。不断扩充的兽用生物生技药品产品线反映了投资者日益增长的信心，全球领先的动物用药品公司正将大量研发预算投入该领域。这一趋势代表了治疗模式的重大演变，也反映了伴侣动物健康市场生技药品细分领域在短期内光明的前景。

拓展兽医远端保健服务

兽医远端保健正逐渐成为伴侣动物医疗保健领域的变革性倡议，它不仅弥合了地域和经济上的就医鸿沟，还提高了医疗服务的效率。随着数位化趋势的兴起，连接宠物饲主和合格兽医的数位平台，例如视讯咨询、聊天和非同步通讯等，正在迅速发展。这些服务在初步分流、术后后续观察、处方笺管理和行为咨询方面特别有效，从而减少了非紧急情况下对线下就诊的需求。穿戴式宠物健康监测设备的集成，能够追踪生命体征、活动量和睡眠模式，从而实现数据驱动的远端健康评估。兽医院正越来越多地采用混合护理模式，将院内服务与数位化管道结合，以提高客户参与度和治疗依从性。在一些关键市场，兽医远端医疗医疗的监管框架正在日趋完善，为兽医和技术提供者提供了更清晰的营运指导。对兽医专用远距远端医疗基础设施（包括人工智慧分诊工具和基于云端的医疗记录整合）的投入不断增加，进一步提升了平台的成熟度和扩充性。这表明，基于远端医疗的照护模式在全球伴侣动物健康市场具有极其广阔的成长前景。

目录

第一章：序言

第二章：调查方法

  • 调查目的
  • 相关利益者
  • 数据来源
    • 主要讯息
    • 次要讯息
  • 市场估值
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章执行摘要

第四章：引言

第五章：全球宠物保健产品市场

  • 市场概览
  • 市场表现
  • 新冠疫情的影响
  • 市场预测

第六章 市场区隔：依动物类型划分

  • 狗
  • 猫
  • 马
  • 其他的

第七章 市场区隔：依产品划分

  • 疫苗
  • 製药
  • 饲料添加剂
  • 诊断
  • 其他的

第八章 市场区隔：依最终用户划分

  • 即时检测/院内检测
  • 兽医医院和诊所
  • 其他的

第九章 市场区隔：依地区划分

  • 北美洲
    • 我们
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第十章 SWOT 分析

第十一章：价值链分析

第十二章：波特五力分析

第十三章：价格分析

第十四章 竞争格局

  • 市场结构
  • 主要企业
  • 主要企业简介
    • Agrolabo SpA
    • Boehringer Ingelheim International GmbH
    • Ceva Sante Animale
    • Dechra
    • Elanco
    • Greencross Vets
    • IDEXX Laboratories, Inc.
    • Indian Immunologicals Ltd.
    • Norbrook
    • Vetoquinol
    • Virbac
    • Zoetis Services LLC
Product Code: SR112026A5482

The global companion animal health market size was valued at USD 29.37 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 59.37 Billion by 2034, exhibiting a CAGR of 7.03% from 2026-2034. North America currently dominates the market, holding a market share of 40.5% in 2025. The region benefits from high pet ownership rates, advanced veterinary infrastructure, widespread pet insurance adoption, and robust government support for animal healthcare standards, which collectively sustain strong demand and underpin the companion animal health market share.

The global companion animal health market is experiencing robust growth driven by a convergence of demographic, economic, and scientific factors. The increasing trend of pet humanization has fundamentally transformed how owners approach animal healthcare, with more individuals treating companion animals as family members and seeking premium medical services. Rising disposable incomes across both developed and emerging economies have expanded the willingness to invest in preventive care, diagnostics, and specialized treatments. Growing awareness of zoonotic diseases has further reinforced the importance of regular veterinary care and vaccination programs. Technological advancements in veterinary diagnostics, including point-of-care testing devices and advanced imaging systems, are enabling earlier and more accurate disease detection. The expansion of veterinary telemedicine services has improved accessibility to healthcare advice in underserved regions. Additionally, the surge in pet adoption, particularly during and after the global pandemic period, has structurally increased the companion animal population, thereby creating a sustained and expanding base of demand for health products and services, reflecting favorable companion animal health market growth prospects globally.

The United States has emerged as a major region in the companion animal health market owing to many factors. The country hosts one of the largest companion animal populations in the world, with pets present in millions of households across urban and rural settings. An extensive network of licensed veterinary clinics, animal hospitals, and specialty care centers forms a strong foundation for service delivery. Federal oversight through agencies such as the US Department of Agriculture and the Food and Drug Administration ensures rigorous standards for pharmaceutical approvals and veterinary product safety. The widespread availability of pet insurance coverage has made advanced treatments financially accessible to a broader segment of pet owners, encouraging more frequent veterinary visits and uptake of specialized therapies. Research and development investments in novel biologics and targeted therapeutics are particularly strong within the country.

COMPANION ANIMAL HEALTH MARKET TRENDS:

Surge in Pet Insurance Adoption

The rising uptake of pet insurance across major markets is significantly reshaping how companion animal healthcare is financed and accessed. As veterinary costs for complex procedures and chronic disease management continue to escalate, more pet owners are turning to insurance plans to manage unexpected medical expenses. This shift is encouraging higher utilization of advanced diagnostics, surgical interventions, and specialist consultations that might otherwise be foregone due to cost constraints. Insurers are increasingly tailoring products to cover a broad range of conditions, from hereditary disorders to dental care and behavioral therapy. The expansion of employer-sponsored pet insurance benefits in North America and parts of Europe has further accelerated enrollment among working-age adults. Technological platforms enabling seamless claims management and policy comparison have lowered barriers to insurance uptake.

Advancements in Veterinary Biologics

The veterinary biologics segment is undergoing a period of rapid scientific advancement, driven by increased research investment and the application of biotechnology platforms to animal health. Novel vaccine formulations leveraging messenger RNA technology are being explored for companion animals, building on methodologies validated during human healthcare applications. Monoclonal antibody therapies have entered the veterinary therapeutics space, offering targeted treatment options for conditions such as allergic dermatitis and osteoarthritis in dogs and cats. These therapies offer compelling advantages over traditional pharmaceuticals, including high specificity, favorable safety profiles, and sustained duration of action. Regulatory agencies in North America and Europe have streamlined approval pathways for priority veterinary biologics, reducing time-to-market for innovative products. Academic-industry collaborations are accelerating the translation of research into commercially viable solutions. The growing pipeline of veterinary biologics reflects broader investment confidence, with major global animal health companies allocating substantial R&D budgets to this area. This trajectory signals a meaningful evolution in treatment paradigms, reflecting positive companion animal health market outlook for the biologics subsegment in the near term.

Expanding Veterinary Telehealth Services

Veterinary telehealth has emerged as a transformative channel within companion animal healthcare, bridging geographic and economic access gaps while enhancing the efficiency of care delivery. Digital platforms connecting pet owners with licensed veterinarians via video consultation, chat, and asynchronous messaging have proliferated following the accelerated digital adoption trends observed in recent years. These services are particularly valuable for initial triage, post-operative monitoring, prescription management, and behavioral consultations, reducing the need for in-person visits for non-emergency cases. The integration of wearable health monitoring devices for pets, capable of tracking vital signs, activity levels, and sleep patterns, is enabling data-driven remote health assessments. Veterinary practices are increasingly adopting hybrid care models that combine in-clinic services with digital touchpoints to improve client engagement and treatment compliance. Regulatory frameworks governing telehealth in veterinary medicine are maturing across key markets, providing greater operational clarity for practitioners and technology providers alike. Growing investment in purpose-built veterinary telehealth infrastructure, including AI-assisted triage tools and cloud-based medical record integration, is further accelerating platform sophistication and scalability. This reflects compelling companion animal health market forecast potential for telehealth-enabled care models globally.

COMPANION ANIMAL HEALTH INDUSTRY SEGMENTATION:

Analysis by Animal Type:

  • Dogs
  • Cats
  • Equine
  • Others

Dogs hold 45.0% of the market share. Dogs represent the largest animal type segment within the companion animal health market, reflecting their status as the most widely owned pet species globally. The deep emotional bonds formed between dogs and their owners drive significant spending on preventive care, vaccinations, diagnostics, and treatment of chronic conditions such as arthritis, dermatological disorders, and diabetes. The sheer diversity of dog breeds, each with distinct health predispositions, creates strong demand for a wide array of specialized pharmaceutical and biological products. Growing awareness of preventive wellness programs, including regular screenings and parasite control, has further elevated healthcare engagement among dog owners. The aging dog population in developed markets is contributing to rising demand for senior-specific health solutions, including joint supplements, pain management therapies, and oncology treatments. Furthermore, the premiumization trend in pet care has led owners to seek high-quality, evidence-based medical interventions for their dogs, sustaining consistent revenue growth within this segment and reinforcing its dominant position across the companion animal health industry worldwide.

Analysis by Product:

  • Vaccines
  • Pharmaceuticals
  • Feed Additives
  • Diagnostics
  • Others

Pharmaceuticals lead the market with a share of 41.0%. Pharmaceuticals represent the cornerstone of companion animal health management, encompassing a broad range of prescription and over-the-counter drugs designed to prevent, treat, and manage diseases across multiple species. The category includes anti-infectives, anti-parasitics, analgesics, anti-inflammatory agents, dermatological preparations, and endocrine therapies, among others. The growing incidence of lifestyle-related conditions in companion animals, including obesity, diabetes, and cardiovascular disorders linked to sedentary environments and processed diets, has amplified pharmaceutical demand. Enhanced regulatory clarity around veterinary drug approvals has facilitated the entry of new formulations with improved efficacy and safety profiles. The development of species-specific dosage forms and palatability-optimized delivery systems has improved owner compliance and treatment adherence. Expansion into novel therapeutic areas, including oncology, neurology, and immunology, reflects the broadening scope of veterinary pharmaceuticals. Continued investment in generic drug development is also improving affordability and access across diverse economic settings, further solidifying pharmaceuticals as the leading product category in the market.

Analysis by End User:

  • Point-of-care Testing/In-house Testing
  • Veterinary Hospitals and Clinics
  • Others

Veterinary hospitals and clinics dominate the market, with a share of 79.8%. These establishments serve as the primary point of contact between companion animals and professional healthcare services, offering comprehensive diagnostic, therapeutic, and surgical capabilities under one roof. The concentration of advanced medical equipment, specialized staff, and established regulatory compliance standards within these settings makes them the preferred channel for complex health interventions, emergency care, and specialist referrals. Rising pet ownership and the growing willingness of owners to invest in preventive wellness programs have translated into higher foot traffic at veterinary facilities worldwide. The ongoing expansion of corporate veterinary chains and multi-specialty animal hospitals across North America, Europe, and Asia-Pacific has enhanced service capacity and standardization. Veterinary hospitals also serve as key distribution points for prescription pharmaceuticals, vaccines, and therapeutic diets, reinforcing their centrality in the health product supply chain. The growing integration of digital tools for appointment scheduling, electronic medical records, and remote monitoring within clinical settings is further strengthening their operational efficiency and competitive position.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America, accounting for 40.5% of the share, holds the leading position in the market. The dominance is further fueled by the exceptionally high pet ownership rate in the region, with a considerable number of households in the United States and Canadian territories boasting the presence of companion animals. The presence of thousands of licensed veterinary clinics, specialty hospitals, and emergency care facilities ensures the provision of top-notch health management services to companion animals in the region. The robust institutional frameworks in place to guide the approval of veterinary products and the management of animal welfare add to the dominance of North America in the companion animal health management industry. The pet insurance culture has increased the affordability of top-notch medical services to pets, allowing for the increased use of diagnostics, specialty treatments, and high-end pharmaceutical products. The high level of consumer expenditure in the companion animal health and wellness industry is a reflection of the culture in the region.

KEY REGIONAL TAKEAWAYS:

UNITED STATES COMPANION ANIMAL HEALTH MARKET ANALYSIS

The United States holds 95.20% of companion animal health in North America. The United States represents the single largest country-level market within the global companion animal health landscape, driven by a combination of structural, cultural, and regulatory factors that consistently support elevated healthcare spending for pets. The country benefits from one of the most extensive veterinary care networks in the world, encompassing general practice clinics, specialty and emergency hospitals, and academic veterinary medical centers engaged in cutting-edge research. Government agencies including the U.S. Department of Agriculture's Center for Veterinary Biologics and the FDA's Center for Veterinary Medicine maintain rigorous oversight frameworks that foster consumer confidence in approved health products. The rapid growth of the pet insurance sector has meaningfully expanded access to costly procedures, including orthopedic surgeries, oncology treatments, and advanced diagnostics. Consumer spending on companion animal health in the United States continues to grow year-on-year, fueled by humanization trends and a shift toward preventive care philosophies. Strong e-commerce channels for pet health products, alongside growing adoption of digital veterinary health platforms, further companion animal health market trends across the United States.

EUROPE COMPANION ANIMAL HEALTH MARKET ANALYSIS

Europe constitutes a significant and steadily expanding contributor to the global companion animal health market, supported by high pet ownership rates, progressive animal welfare legislation, and a well-established veterinary services sector. The United Kingdom, Germany, France, Italy, and Spain represent the largest national markets within the region, each characterized by dense veterinary clinic networks and sophisticated distribution systems for animal health products. European regulatory bodies, including the European Medicines Agency, apply stringent standards to veterinary pharmaceutical approvals, ensuring product quality and efficacy across member states. The growing adoption of preventive healthcare practices, including routine vaccination, parasite control, and dental care programs, reflects a cultural shift toward proactive animal health management. Rising elderly pet populations in several Western European countries are creating demand for geriatric care solutions, including mobility aids, pain management therapies, and specialized nutritional products.

ASIA-PACIFIC COMPANION ANIMAL HEALTH MARKET ANALYSIS

Asia-Pacific represents the fastest-growing regional market for companion animal health, driven by rapidly rising pet ownership in urbanizing economies including China, Japan, South Korea, India, and Australia. Expanding middle-class populations with increasing disposable incomes are embracing companion animals as lifestyle additions, fueling demand for veterinary services and health products. Urbanization and changing family structures, particularly the growing prevalence of single-person and childless households, have reinforced the emotional significance attached to pets across the region. Veterinary infrastructure is expanding rapidly, with significant investments in clinic networks, pharmaceutical distribution, and diagnostic laboratories in key markets. Government initiatives promoting animal disease surveillance and vaccination campaigns are improving formal healthcare penetration for companion animals.

LATIN AMERICA COMPANION ANIMAL HEALTH MARKET ANALYSIS

Latin America represents an emerging growth opportunity within the global companion animal health market, with Brazil and Mexico serving as the primary drivers of regional demand. Rising pet ownership rates, particularly in urban centers, and growing awareness of animal welfare standards are elevating healthcare spending for companion animals across the region. Expanding middle-class segments are increasingly adopting preventive veterinary care practices, including routine vaccinations and parasite management. The rollout of regional veterinary hospital chains and improved pharmaceutical distribution networks is broadening access to quality health products.

MIDDLE EAST AND AFRICA COMPANION ANIMAL HEALTH MARKET ANALYSIS

The Middle East and Africa region represents an emerging and gradually evolving segment within the companion animal health market, driven by rising urbanization, increasing pet adoption in metropolitan areas, and growing awareness of formal veterinary care. The Gulf Cooperation Council countries, particularly the United Arab Emirates and Saudi Arabia, are demonstrating the strongest demand growth, supported by affluent urban populations and a cultural shift toward pet ownership. Government initiatives across several African nations to control zoonotic diseases are indirectly stimulating investment in companion animal health infrastructure.

COMPETITIVE LANDSCAPE:

The global companion animal health market is characterized by a moderately consolidated competitive profile, with various multinational corporations dominating the market along with a significant number of mid-size companies that specialize in the field of animal health. The major companies in the field continue to invest heavily in research and development activities to enhance their product offerings in the fields of pharmaceuticals, vaccines, and diagnostics, among others. Mergers and acquisitions, partnerships, and collaborations have been significant mechanisms adopted by companies to compete with their peers in the field of animal health products. The various challenges faced by the companies, including the high cost of clinical trials for the development of novel biological products, the high cost of generic products, and the high cost of complying with various regulations in various markets, have been influencing the overall competitive dynamics of the market. The companies are also focusing on the development of precision medicine platforms, data-based disease management platforms, and direct-to-consumer digital initiatives to compete with their peers in the field of animal health products. Partnerships between research institutions and contract development organizations have been driving the overall innovation-based competition in the field of animal health products.

The report provides a comprehensive analysis of the competitive landscape in the companion animal health market with detailed profiles of all major companies, including:

  • Agrolabo S.p.A.
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Dechra
  • Elanco
  • Greencross Vets
  • IDEXX Laboratories Inc.
  • Indian Immunologicals Ltd.
  • Norbrook
  • Vetoquinol
  • Virbac
  • Zoetis Services LLC

KEY QUESTIONS ANSWERED IN THIS REPORT

1. How big is the companion animal health market?

2. What is the future outlook of the companion animal health market?

3. What are the key factors driving the companion animal health market?

4. Which region accounts for the largest companion animal health market share?

5. Which are the leading companies in the global companion animal health market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Companion Animal Health Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Animal Type

  • 6.1 Dogs
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Cats
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Equine
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Product

  • 7.1 Vaccines
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Pharmaceuticals
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Feed Additives
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Diagnostics
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Point-of-care Testing/In-house Testing
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Veterinary Hospitals and Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Agrolabo S.p.A.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Boehringer Ingelheim International GmbH
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Ceva Sante Animale
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Dechra
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Elanco
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
    • 14.3.6 Greencross Vets
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 IDEXX Laboratories, Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Indian Immunologicals Ltd.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Norbrook
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Vetoquinol
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
    • 14.3.11 Virbac
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Zoetis Services LLC
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Companion Animal Health Market: Major Drivers and Challenges
  • Figure 2: Global: Companion Animal Health Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Companion Animal Health Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Companion Animal Health Market: Breakup by Animal Type (in %), 2025
  • Figure 5: Global: Companion Animal Health Market: Breakup by Product (in %), 2025
  • Figure 6: Global: Companion Animal Health Market: Breakup by End User (in %), 2025
  • Figure 7: Global: Companion Animal Health Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Companion Animal Health (Dogs) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Companion Animal Health (Dogs) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Companion Animal Health (Cats) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Companion Animal Health (Cats) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Companion Animal Health (Equine) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Companion Animal Health (Equine) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Companion Animal Health (Other Animal Types) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Companion Animal Health (Other Animal Types) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Companion Animal Health (Vaccines) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Companion Animal Health (Vaccines) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Companion Animal Health (Pharmaceuticals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Companion Animal Health (Pharmaceuticals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Companion Animal Health (Feed Additives) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Companion Animal Health (Feed Additives) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Companion Animal Health (Diagnostics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Companion Animal Health (Diagnostics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Companion Animal Health (Other Products) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Companion Animal Health (Other Products) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Companion Animal Health (Point-of-care Testing/In-house Testing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Companion Animal Health (Point-of-care Testing/In-house Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Global: Companion Animal Health (Veterinary Hospitals and Clinics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Global: Companion Animal Health (Veterinary Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Global: Companion Animal Health (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Global: Companion Animal Health (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: North America: Companion Animal Health Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: North America: Companion Animal Health Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: United States: Companion Animal Health Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: United States: Companion Animal Health Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: Canada: Companion Animal Health Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: Canada: Companion Animal Health Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: Asia-Pacific: Companion Animal Health Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: Asia-Pacific: Companion Animal Health Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: China: Companion Animal Health Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: China: Companion Animal Health Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: Japan: Companion Animal Health Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: Japan: Companion Animal Health Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: India: Companion Animal Health Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: India: Companion Animal Health Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: South Korea: Companion Animal Health Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: South Korea: Companion Animal Health Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Australia: Companion Animal Health Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Australia: Companion Animal Health Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Indonesia: Companion Animal Health Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Indonesia: Companion Animal Health Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: Others: Companion Animal Health Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: Others: Companion Animal Health Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: Europe: Companion Animal Health Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: Europe: Companion Animal Health Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Germany: Companion Animal Health Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Germany: Companion Animal Health Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: France: Companion Animal Health Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: France: Companion Animal Health Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: United Kingdom: Companion Animal Health Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: United Kingdom: Companion Animal Health Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Italy: Companion Animal Health Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Italy: Companion Animal Health Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Spain: Companion Animal Health Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Spain: Companion Animal Health Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Russia: Companion Animal Health Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Russia: Companion Animal Health Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Others: Companion Animal Health Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Others: Companion Animal Health Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Latin America: Companion Animal Health Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Latin America: Companion Animal Health Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Brazil: Companion Animal Health Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Brazil: Companion Animal Health Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Mexico: Companion Animal Health Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Mexico: Companion Animal Health Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 76: Others: Companion Animal Health Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 77: Others: Companion Animal Health Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 78: Middle East and Africa: Companion Animal Health Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 79: Middle East and Africa: Companion Animal Health Market: Breakup by Country (in %), 2025
  • Figure 80: Middle East and Africa: Companion Animal Health Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 81: Global: Companion Animal Health Industry: SWOT Analysis
  • Figure 82: Global: Companion Animal Health Industry: Value Chain Analysis
  • Figure 83: Global: Companion Animal Health Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Companion Animal Health Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Companion Animal Health Market Forecast: Breakup by Animal Type (in Million USD), 2026-2034
  • Table 3: Global: Companion Animal Health Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 4: Global: Companion Animal Health Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 5: Global: Companion Animal Health Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Companion Animal Health Market: Competitive Structure
  • Table 7: Global: Companion Animal Health Market: Key Players